Trials / Terminated
TerminatedNCT01837082
Iron in Congestive Heart Failure
Randomized, Double-blind, Placebo-controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients With Congestive Heart Failure
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of Ulm · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis to be tested is whether treatment with intravenous iron (ferric carboxymaltose) will improve left-ventricular ejection fraction in patients with heart failure and iron deficiency as determined by cardiac magnetic resonance imaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ferric carboxymaltose | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2013-04-22
- Last updated
- 2016-05-13
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01837082. Inclusion in this directory is not an endorsement.